Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109306

Decreased Heat-Labile Opsonic Activity and Complement Levels Associated with Evidence of C3 Breakdown Products in Infected Pleural Effusions

Pablo D. Lew, Rudolf Zubler, Pierre Vaudaux, Jean J. Farquet, Francis A. Waldvogel, and Paul-Henri Lambert

Infectious Disease Division and the World Health Organization Immunology Research and Training Center, University of Geneva, 1211 Geneva 4, Switzerland

Department of Medicine, University of Geneva, 1211 Geneva 4, Switzerland

Find articles by Lew, P. in: PubMed | Google Scholar

Infectious Disease Division and the World Health Organization Immunology Research and Training Center, University of Geneva, 1211 Geneva 4, Switzerland

Department of Medicine, University of Geneva, 1211 Geneva 4, Switzerland

Find articles by Zubler, R. in: PubMed | Google Scholar

Infectious Disease Division and the World Health Organization Immunology Research and Training Center, University of Geneva, 1211 Geneva 4, Switzerland

Department of Medicine, University of Geneva, 1211 Geneva 4, Switzerland

Find articles by Vaudaux, P. in: PubMed | Google Scholar

Infectious Disease Division and the World Health Organization Immunology Research and Training Center, University of Geneva, 1211 Geneva 4, Switzerland

Department of Medicine, University of Geneva, 1211 Geneva 4, Switzerland

Find articles by Farquet, J. in: PubMed | Google Scholar

Infectious Disease Division and the World Health Organization Immunology Research and Training Center, University of Geneva, 1211 Geneva 4, Switzerland

Department of Medicine, University of Geneva, 1211 Geneva 4, Switzerland

Find articles by Waldvogel, F. in: PubMed | Google Scholar

Infectious Disease Division and the World Health Organization Immunology Research and Training Center, University of Geneva, 1211 Geneva 4, Switzerland

Department of Medicine, University of Geneva, 1211 Geneva 4, Switzerland

Find articles by Lambert, P. in: PubMed | Google Scholar

Published February 1, 1979 - More info

Published in Volume 63, Issue 2 on February 1, 1979
J Clin Invest. 1979;63(2):326–334. https://doi.org/10.1172/JCI109306.
© 1979 The American Society for Clinical Investigation
Published February 1, 1979 - Version history
View PDF
Abstract

Heat-labile opsonic activity was measured simultaneously in serum and pleural fluid of patients with transudates, infectious exudates (with positive or negative bacterial culture) and neoplastic exudates, using two different complement-dependent phagocytic tests: the killing of Staphylococcus aureus Wood 46 variant strain (K50 opsonic titers) and the assessment of ingestion rate of endotoxin-coated paraffin particles (Oil Red 0 uptake test). K50 opsonic titers were lower in culture-positive pleural effusions as compared to culture-negative (P < 0.002) or neoplastic effusions (P < 0.002). These results were corroborated by the Oil Red 0 uptake test. The data obtained with the two assays showed a significant correlation (P < 0.001).

The hemolytic activity of complement (CH50) as well as the levels of C3 breakdown product, C3d, were measured in the same sera and pleural fluid samples and in an additional group of patients with pleural effusions of the same etiology. Effusions with positive cultures showed lower CH50 values (P < 0.01) and higher C3d values (P < 0.05) when compared to culture-negative pleural fluids. Finally, evidence for immune complexes in pleural effusions and sera was looked for by determination of Clq binding activity. Levels were higher in culture-positive effusions when compared to culture-negative fluids (P = 0.005).

K50 opsonic titers showed a positive correlation with CH50 values (P < 0.001) for all fluids tested. Similarly Clq binding activity correlated with C3d levels in effusions of infectious origin (P = 0.05). Recovery experiments using the various bacterial species isolated from culture-positive pleural effusions showed evidence of complement inactivation upon incubation with pooled sera at concentrations of 107-108 microorganisms/ml.

These results indicate that one important reason for bacterial persistence in empyema may be decreased opsonization secondary to local consumption of complement.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 326
page 326
icon of scanned page 327
page 327
icon of scanned page 328
page 328
icon of scanned page 329
page 329
icon of scanned page 330
page 330
icon of scanned page 331
page 331
icon of scanned page 332
page 332
icon of scanned page 333
page 333
icon of scanned page 334
page 334
Version history
  • Version 1 (February 1, 1979): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts